Skip to main content
OpenTrials
Completed

NCT Number: NCT05296187

Efficacy of TEAS On Prevention of Propofol Injection Pain in Children

The purpose of this study is to determine the efficacy of transcutaneous electrical acupoint stimulation for the prevention of propofol injection pain in children.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Injection Site

Age range

6 year–13 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Betul Kozanhan

Konya, 42005, Turkey (Türkiye)

About this study

Pain from the injection of propofol is a common side effect during anesthetic practice. Various methods have been used to reduce this pain. This prospective, randomized study was designed to determine the efficacy of transcutaneous electrical acupuncture point stimulation in reducing propofol injection pain in children.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ASA I-II and aged 6-13 years patents who will undergo elective surgery under general anesthesia

Exclusion criteria

  • patients with propofol allergy
  • patients who have renal, hepatic, cardiac, neurological, psychiatric disease
  • Cardiac and cranial surgery
  • Pacemaker,
  • Emergency surgery and patients requiring rapid serial induction

Treatment and study plan

TEAS

Device

Transcutaneous electrical acupuncture stimulation

Primary outcomes

  1. Pain with propofol injection

    Time frame: 5 minutes

    pain will be assessed using a four point behavioral scale: 1= no pain (no reaction); 2= mild pain (grimace); 3= moderate pain (grimace+cry); 4= severe pain (cry+withdrawal)

Sponsors and collaborators

Lead sponsor

Konya Meram State Hospital

Other

Registry information

Official study title

Efficacy of Transcutaneous Electrical Acupuncture Point Stimulation (TEAS) for the Prevention of Propofol Injection Pain in Children

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Mar 25, 2022
Registry last updated
Apr 9, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.